2014-12-23T10:07:06-06:00 2014-03-31 ERNST & YOUNG US LLP 1901 SIXTH AVENUE NORTH SUITE 1200 BIRMINGHAM AL 35203 990 2013-04-01 751835298 SUSAN G KOMEN BREAST CANCER FOUNDATION INC % DR JUDITH SALERNO SUSA 9728551600 5005 LBJ Freeway Suite 250 Dallas TX 752446125 JUDITH SALERNO CEO 2014-12-23 KATHY PITTS P00292940 2013 2015-11-30 17:44:51Z Susan G Komen Dr Judith Salerno 5005 LBJ Freeway Dallas TX 752446125 186185866 false 7164 X www.komen.org X 1982 TX AT SUSAN G. KOMEN, WE ARE COMMITTED TO ENDING BREAST CANCER FOREVER BY EMPOWERING PEOPLE, ENERGIZING SCIENCE TO FIND THE CURES AND ENSURING QUALITY CARE FOR ALL PEOPLE, EVERYWHERE 10 9 280 7792 0 118656952 91606572 26281480 23368295 7368340 12781994 -5984835 -4716975 146321937 123039886 49882918 38325752 0 0 25941318 24001926 1598294 1906359 13956943 82440666 61523637 159863196 125757674 -13541259 -2717788 294589250 282716020 175912920 155720348 118676330 126995672 X At Susan G. KOMEN, we are committed to ending breast cancer forever by empowering people, energizing science to find the cures and ensuring quality care for all people, everywhere. false false 45608289 35112217 23368295 Grants to other non-profit organizations to support breast cancer research, as well as research resources and conferences that further the breast cancer research agenda. See Schedule O for additional details. 50963999 2329301 128569 Public health education programs to increase the public's awareness of breast cancer including, among other things, early detection and treatment. See Schedule O for additional details. 3285777 884234 0 Breast Cancer screening, diagnosis and treatment programs and grants. See schedule O for additional details. 99858065 true true false true false false false false false true true true false false false true false true false false true true false true true false false true false true false false false false false false false false true false false false false false false false false true 187 0 true 280 true false false false false false true true false false false false X 10 9 false false true false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DC DC FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT UT VA WA WV WI X X DR JUDITH SALERNO 9728551600 5005 LBJ Freeway Suite 250 Dallas TX 752446125 Linda Custard CHAIR OF THE BOARD (BEG. 4/13) 30.0 0.0 X X 0 0 0 Jane Abraham BOD Member 1.0 0.0 X 0 0 0 Connie O'Neill BOD Member & Treasurer 1.0 0.0 X X 0 0 0 John D Raffaelli BOD Member 1.0 0.0 X 0 0 0 Tricia Ory BOD Member 1.0 0.0 X 0 0 0 Alan D Feld BOD Member 1.0 0.0 X 0 0 0 Dr Olofunmlayo Olopade BOD Member 1.0 0.0 X 0 0 0 Nancy G Brinker Founder & CHAIR GLOBAL STRTGY 55.0 0.0 X X 480784 0 25702 Linda Wilkins BOD Member (Begin 4/13) 1.0 0.0 X 0 0 0 Susie Knopf BOD Member (Begin 4/13) 1.0 0.0 X 0 0 0 Mark Nadolny Chief Financial Officer 55.0 0.0 X 319324 0 33820 Dr Judith Salerno CEO (Begin 9/13) 55.0 0.0 X 209120 0 3399 Ellen Willmott Gen Counsel & Secy 55.0 0.0 X 257129 0 16634 Lesley Lurie Assistant Secretary 55.0 0.0 X 193989 0 27029 Lynn Erdman VP Community Health (End 5/13) 55.0 0.0 X 154306 0 17159 Kay Merrell VP, Human Resources 55.0 0.0 X 211345 0 29318 David Dawson VP, Information Technology 55.0 0.0 X 215589 0 33841 Chandini Portteus CHIEF MISSION OFFCR (BEG 6/13) 55.0 0.0 X 245129 0 25953 Dorothy Jones VP, Marketing (End 12/13) 55.0 0.0 X 291286 0 25213 Carol Corcoran SVP Global Networks (End 8/13) 55.0 0.0 X 161298 0 16651 Miguel Perez VP Affiliate Ntwrk (BEG. 9/14) 55.0 0.0 X 146771 0 8392 Wendy Carter Director, Global Outreach 55.0 0.0 X 169046 0 7569 Andrea Rader Managing Director, Comm. 55.0 0.0 X 158075 0 21587 Victoria Wolodzko Mng Director, Grants & PrOG AD 55.0 0.0 X 154807 0 16874 Adine Zornow Director, Development 55.0 0.0 X 144175 0 12785 3512173 0 321926 44 false true false Event 360 Inc 205 N Michigan Avenue Chicago IL 606015927 Event Management 7608194 Merkle Response Services Inc PO Box 64897 Baltimore MD 21264 Donation processing 2470128 Convio Inc PO Box 671445 Dallas TX 752671445 Donation processing 1683144 Radarworks 6100 Wilshire Blvd LOS ANGELES CA 90048 MARKETING 1479909 Pangea Global AIDS Foundation 436 14th Street Suite 920 OAKLAND CA 94612 Screening program 664000 25 1192505 41977575 48436492 28566 91606572 Affiliate Payments 900099 23368295 23368295 0 0 23368295 3881425 3881425 0 183321 183321 0 0 0 63346545 0 54445976 0 8900569 0 8900569 8900569 2695217 41977575 8160822 -5465605 -5465605 0 502751 539182 -36431 -36431 Support Services 900099 165000 165000 0 0 Other income 900099 436740 0 0 436740 601740 123039886 23496864 0 7936450 X 34882044 34882044 0 0 3443708 3443708 0 0 2739298 2175144 260139 304015 0 0 0 0 17493473 11721557 4601424 1170492 696331 474176 173086 49069 1881105 1237572 506866 136667 1191719 799125 310276 82318 0 0 0 0 257305 146119 93916 17270 599029 388820 150556 59653 0 0 0 0 1906359 1906359 157062 0 157062 0 0 0 0 0 13074095 8880374 1703522 2490199 9566002 5572207 173799 3819996 2567558 2038773 243830 284955 0 0 0 0 1437475 974525 373694 89256 1803432 1271667 341435 190330 0 0 0 0 1604198 1118842 358721 126635 0 0 0 0 0 0 0 0 1212043 827576 269674 114793 258743 202405 39241 17097 CONSULTING & PROF. SVCS. 15061253 12848166 932987 1280100 EVENT PRODUCTION 3914197 3100657 377431 436109 BANK FEES 2056177 1400600 97575 558002 EQUIP. RENTAL & MAINT. 1031952 248368 381465 402119 6923116 6105640 395967 421509 125757674 99858065 11942666 13956943 X 42314252 25979076 1375717 14959459 0 0 28421714 12278347 41066118 30072080 729495 446048 0 0 0 0 4170597 0 399594 259648 1812789 1185467 10956310 10012955 1516020 943355 205933377 217483471 10539546 20021804 0 0 0 0 0 25800 294589250 282716020 17873404 12764711 156557964 142210195 1481552 745442 0 0 0 0 0 0 0 0 0 0 0 0 175912920 155720348 X 81533610 94533979 36817720 32136693 325000 325000 118676330 126995672 294589250 282716020 X -2717788 8203586 -283448 3116992 X false true X true false X 134999587 174658160 159779664 118656952 91606572 679700935 0 0 0 0 0 0 0 0 0 0 134999587 174658160 159779664 118656952 91606572 679700935 4030049 675670886 3548746 3812083 4528150 4810808 4064746 20764533 0 0 0 0 0 2589864 84038 378313 351342 436740 3840297 704305765 175779379 0.95934 0.96293 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 68694 0 29561 0 98255 113815008 240872562 113815008 240970817 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 552301 656218 144834 98255 1451608 250000 250000 250000 250000 1000000 1500000 439745 519831 83839 68694 1112109 Lobbying Expenses Schedule C, Part II-A Public policy initiatives have the potential to impact people touched by BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO ELIMINATE BREAST CANCER AS A MAJOR HEALTH PROBLEM. 1325000 0 23736 2469 1346267 1325000 0 21 0 21 1325000 1225000 100000 33 0 33 1325000 1225000 608 0 608 1225000 1225000 4284 -4284 0 0 1225000 0.75000 0.25000 false false 0 795974 795974 2486433 2237077 249356 7673903 6979904 693999 943355 LONG/SHORT EQUITY FUND 20021804 F 20021804 0 0 X Intended use of endowment funds Schedule D, Part V, Line 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS; THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS; AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES. FIN 48 (ASC 740) Financial Statement Disclosure Schedule D, Part X, Line 2 The Organization is subject to a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. There were no uncertain tax positions recorded in the consolidated financial statements at March 31, 2014 or March 31, 2013. true Central America and the Caribbean 0 0 Grantmaking EDUCATION GRANTS 256511 East Asia and the Pacific 0 0 Grantmaking RESEARCH GRANTS 184502 Europe (Including Iceland and Greenland) 0 0 Grantmaking RESEARCH GRANTS 1342910 Middle East and North Africa 0 0 Grantmaking EDUCATION GRANTS 37500 North America 0 0 Grantmaking RESEARCH GRANTS 936814 South America 0 0 Grantmaking EDUCATION GRANTS 278472 Sub-Saharan Africa 0 0 Grantmaking EDUCATION GRANTS 25000 Central America and the Caribbean 0 0 Grantmaking RESEARCH GRANTS 14500 Europe (Including Iceland and Greenland) 0 0 Grantmaking EDUCATION GRANTS 110000 North America 0 0 Grantmaking EDUCATION GRANTS 257500 Central America and the Caribbean 0 4 Program Services EDUC & EVENT SUPPORT 35597 Europe (Including Iceland and Greenland) 0 6 Program Services EDUC & EVENT SUPPORT 56247 Middle East and North Africa 0 4 Program Services EDUC & EVENT SUPPORT 35757 North America 0 12 Program Services EDUC & EVENT SUPPORT 104733 South America 0 5 Program Services EDUC & EVENT SUPPORT 60835 0 31 0 31 3736878 3736878 Sub-Saharan Africa Education 25000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 180000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 152372 WIRE TRANSFR Central America and the Caribbean EDUCATION 25000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 10000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 33500 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 40000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 218000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 150000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 150000 WIRE TRANSFR Central America and the Caribbean Research 14500 WIRE TRANSFR Central America and the Caribbean EDUCATION 125000 WIRE TRANSFR North America EDUCATION 62500 WIRE TRANSFR South America EDUCATION 23345 WIRE TRANSFR South America EDUCATION 7500 WIRE TRANSFR South America EDUCATION 48768 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION 100000 WIRE TRANSFR North America Research 117140 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 35000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 199038 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION 10000 WIRE TRANSFR Middle East and North Africa EDUCATION 32500 WIRE TRANSFR North America Research 304994 WIRE TRANSFR North America EDUCATION 30000 WIRE TRANSFR Central America and the Caribbean EDUCATION 37400 WIRE TRANSFR North America Education 125000 WIRE TRANSFR North America Research 224500 WIRE TRANSFR Central America and the Caribbean EDUCATION 19111 WIRE TRANSFR North America 40000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 175000 WIRE TRANSFR Central America and the Caribbean EDUCATION 50000 WIRE TRANSFR South America Education 198860 WIRE TRANSFR East Asia and the Pacific Research 184502 WIRE TRANSFR North America EDUCATION 40000 WIRE TRANSFR North America Research 250180 WIRE TRANSFR 35 false false false false false false Procedures for Monitoring Use of grant funds outside of the UNITED STATES Schedule F, Part I, Line 2 All research, education, screening, and treatment grantees are required to submit, at a minimum, annual financial and progress reports and any change requests they may have for their projects. All progress reports and requests are reviewed by qualified staff. See Schedule I, Part IV for more details. X X X X X true Merkle Inc Direct Marketing false 15100931 1906359 13194572 15100931 1906359 13194572 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY GBL RACE FR CUR 2469681 1722372 747309 34605 23066 35581 116834 BRST CANCR 3DY 38510913 37000135 1510778 14058 1833727 1604083 4187284 2 3692198 3255068 437130 779 241787 69018 44672792 41977575 2695217 49442 1856793 1881451 4373136 8160822 -5465605 Schedule G Part II Net Income Summary GROSS RECEIPTS ARE REDUCED BY THE AMOUNT OF CONTRIBUTIONS, PER IRS INSTRUCTIONS. THE CONTRIBUTIONS FOR FISCAL YEAR 2014 WERE $42 MILLION. true Adventist Healthcare Inc 1801 Research Blvd Suite 300 Rockville MD 20850 521532556 501(C)(3) 114625 Screening Alaska Native Tribal Health Consortium 4000 Ambassador Drive Anchorage AL 99508 920162721 501(C)(3) 62500 Screening Albert Einstein College of Med Yeshiva U 1300 Morris Park Avenue Belfer 110 Bronx NY 104611975 131624225 501(C)(3) 150000 Research Alexandria Neighborhood Health Services 2445 Army Navy Dr Arlington VA 22206 541849891 501(C)(3) 241437 Education, Screening, and Treatment American Association for Cancer Research 615 Chestnut Street 17th Fl Philadelphia PA 191064404 236251649 501(C)(3) 684000 Research American Association on Health & Disabil 110 N Washington Street Suite 328 Rockville MD 20850 521884887 501(C)(3) 124999 Education American Cancer Society 250 Williams Street Atlanta GA 30303 580659875 501(C)(3) 9500 Education American Jewish Joint 711 Third Avenue New York NY 100174014 131656634 501(C)(3) 224719 Education American Society of Clinical Oncology 2318 Mill Road Suite 800 Alexandria VA 22314 136180880 501(C)(3) 400000 Research Arlington Free Clinic 2921 11th Street South Arlington VA 22204 541671883 501(C)(3) 354300 Education, Screening, and Treatment Baylor College Medicine One Baylor Plaza BCM 206 Houston TX 770303411 741613878 501(C)(3) 989608 Research Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston MA 02215 042103881 501(C)(3) 466000 Research Boat People SOS 6066 Leesburg Pike 100 Falls Church VA 220412220 541563619 501(C)(3) 150000 Education, Screening, and Treatment Boston University 580 Harrison Avenue 3-W Boston MA 02118 042103547 501(C)(3) 47242 Research Brigham and Womens Hospital PO Box 3149 Boston MA 022413149 042312909 501(C)(3) 581780 Research Burnham Institute for Medical Research 10901 North Torrey Pines Road La Jolla CA 92037 510197108 501(C)(3) 120000 Research Cancer Care 275 Seventh Avenue New York NY 10001 131825919 501(C)(3) 250000 Treatment Capitol City Area Health Education Cente 1700 East Capitol Street NE Ste E Washington DC 20003 263301051 501(C)(3) 300000 Education, Screening, and Treatment CASA of Maryland Inc 8151 15th Avenue Hyattsville MD 20783 521372972 501(C)(3) 70764 Education Childrens Hospital Boston PO Box 414413 Boston MA 022414413 042774441 501(C)(3) 23981 Research Cincinnati Childrens Hospital Medical 3333 Burnet Avenue ML 7030 Cincinnati OH 45229 310833936 501(C)(3) 150000 Research Cleveland Clinic Foundation 9500 Euclid Avenue P84 Cleveland OH 44195 340714585 501(C)(3) 37229 Research Cold Spring Harbor Laboratory 1 Bungtown Road Cold Spring Harbor NY 11724 112013303 501(C)(3) 276825 Research Columbia University Medical Center 615 W 131st Street Studebaker 3rd New York NY 10027 135598093 501(C)(3) 381590 Research Cornell University 341 Pine Tree Road Ithaca NY 14850 150532082 501(C)(3) 48000 Research Dana Farber Cancer Institute 44 Binney Street Mail Stop 439C Boston MA 02115 042263040 501(C)(3) 1494366 Research Dartmouth College 63 South Main Street Hanover NH 03755 020222111 501(C)(3) 63738 Research Duke University Medical Center 2200 W Main Street Suite 300 Durham NC 27705 560532129 501(C)(3) 2682761 Research ECOG Research and Education Foundation 1818 Market Street Philadelphia PA 19109 391723095 501(C)(3) 100000 Research Emory University Winship Cancer Inst PO Box 935084 Atlanta GA 311935084 580566256 501(C)(3) 238845 Research Ethiopian Community Development Council 901 S Highland Street Arlington VA 22204 521308986 501(C)(3) 151471 Education, Treatment Facing Our Risk of Cancer Empowered 16057 Tampa Palms Blvd W 373 Tampa FL 33647 650927702 501(C)(3) 40000 Education Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 232003072 501(C)(3) 150000 Research Fred Hutchinson Cancer Research Center PO Box 19024 Mailstop J6-330 Seattle WA 981091024 563744111 501(C)(3) 248120 Research Fred Hutchinson Cancer Research 1100 Fairview Ave N J6-500 Seattle WA 981091024 237156071 501(C)(3) 199907 Research Friends of Cancer Research 1800 M St NW Washington DC 20036 521983273 501(C)(3) 32000 Research George Washington University 45155 Research Place Ashburn VA 20147 530196584 501(C)(3) 273333 Education, Research, Screening and Treatment Georgetown University LCC LL Level Room S155 Washington DC 20007 530196603 501(C)(3) 856579 Research Greater Baden Medical Services Inc 7450 Albert Road 3-321 Brandywine MD 20316 520961414 501(C)(3) 199900 Screening and Treatment Harvard Medical School 1350 Massachusetts Ave Cambridge MA 02138 042103580 501(C)(3) 342500 Education, Research Henry Ford Health System One Ford Place 5E Detroit MI 48202 381357020 501(C)(3) 161758 Research Hudson-Alpha Institute for Biotechnology 601 Genome Way Huntsville AL 35801 432059317 501(C)(3) 435444 Research Indiana University School of Medicine Financial Mgmt Svcs PO Box 66057 Indianapolis IN 462666057 356001673 501(C)(3) 2050387 Research International Breast Cancer 660 John Nolan Drive Madison WI 53711 391766858 501(C)(3) 29279 Research International Scholarship & Tuition Serv 1321 Murfreesboro Road Nashville TN 37217 621247492 501(C)(3) 15000 Education Johns Hopkins University 1101 East 33rd Street Eastern C220 Baltimore MD 21218 520595110 501(C)(3) 708709 Research Korean Community Svc Ctr of Greater WA 7700 Little River Turnpike 406 Annandale VA 22003 521128174 501(C)(3) 54600 Screening Lankenau Institute for Medical Research 100 Lancaster Avenue Wynnewood PA 19096 232175659 501(C)(3) 8686 Research Lawrence Berkeley National Laboratory PO Box 528 Berkeley CA 94701 942951741 501(C)(3) 60279 Research Leland Stanford Jr University PO Box 44253 San Francisco CA 941444253 941156365 501(C)(3) 60000 Research Living Beyond Breast Cancer 354 West Lancaster Avenue Haverford PA 19041 232734689 501(C)(3) 120000 Education Lutheran Hospital Association of 106 Blanca Avenue Alamosa CO 81101 840255530 501(C)(3) 61692 Screening Maasai Wilderness Conservation Fund PO Box 1413 Santa Barbara CA 93102 660627488 501(C)(3) 50000 Education Maryland Dept of Health & Mental Hygien 201 West Preston Street Room 542 Baltimore MD 212012398 526002033 501(C)(3) 62425 Screening Massachusetts General Hospital 101 Huntington Ave Suite 3 Boston MA 02199 042697983 501(C)(3) 298220 Research Mayo Clinic and Foundation 4500 San Pablo Rd Jacksonville FL 322241865 416011702 501(C)(3) 407542 Research Mayo Clinic Rochester 200 First Street SW PO Box 4008 Rochester MN 559034008 416011702 501(C)(3) 413465 Research Memorial Sloan-Kettering Cancer Ctr 633 3rd Avenue 28th Floor New York NY 10017 131924236 501(C)(3) 277088 Research Mercy Medical Ctr 301 St Paul Place Baltimore MD 21202 521495113 501(C)(3) 279850 Research Metastatic Breast Cancer Network 211 E 18th Street New York City NY 10003 205545238 501(C)(3) 16500 Education Methodist Hospital Research Institute PO Box 4805 Houston TX 772104805 870721923 501(C)(3) 47958 Research Metropolitan Chicago Breast Cancer 1645 W Jackson Blvd Ste 450 Chicago IL 606123244 262264895 501(C)(3) 125001 Screening Michigan State University 301 Administration Building East Lansing MI 48824 386005984 501(C)(3) 150000 Research Mount Sinai School of Medicine 633 Third Avenue New York NY 10017 136171197 501(C)(3) 210000 Research Muslim Community Center Medical Clinic 15200 Newhampshire Avenue Silver Spring MD 209055631 521072792 501(C)(3) 281912 Education, Screening, and Treatment National Academy of Sciences 730 15th Street NW Washington DC 20005 530196932 501(C)(3) 70000 Research Natl Inst of Environmental Health Scienc Mail Drop B2-03 PO Box 12233 Research Triangle Park NC 27709 520852115 501(C)(3) 53222 Research New York University School of Med One Park Avenue 11th Floor New York NY 10016 135562308 501(C)(3) 110000 Research Northwestern University 633 Clark Evanston IL 60208 362167817 501(C)(3) 109104 Research and Screening Nueva Vida Inc 2000 P Street NW Suite 300 Washington DC 20036 541943145 501(C)(3) 415569 Education, Screening, and Treatment Oncology Nursing Society 125 Enterprise Drive Pittsburgh PA 152751214 251410081 501(C)(3) 49845 Education Oregon Health & Science University 0690 SW Bancroft Street Portland OR 97239 237083114 501(C)(3) 1908872 Research Partners for Cancer Care and Prevention 10 East Lee Street Unit 1901 Baltimore MD 21202 451605551 501(C)(3) 26310 Education Patient Advocate Foundation 421 Butler Farm Road Hampton VA 23666 541806317 501(C)(3) 1375000 Treatment Pennsylvania State Univ College of Medi MCG230 PO Box 850 Hershey PA 17033 246000376 501(C)(3) 856502 Research Polytechnic Institute 6 Metrotech Center New York NY 11201 111630820 501(C)(3) 29006 Research Prevent Cancer Foundation 1600 Duke Street Alexandria VA 22209 521429544 501(C)(3) 271176 Education and Screening Princeton University 701 Carnegie Center Princeton NJ 08540 210634501 501(C)(3) 20000 Research Program for Appropriate PO Box 900922 Seattle WA 98109 911157127 501(C)(3) 558550 Education Project Concern International 121 E 31st Street National City CA 91950 952248462 501(C)(3) 25000 Education Proteogenomics Research Institute 11107 Roselle Street San Diego CA 92121 800418281 501(C)(3) 40000 Research Providence Health Foundation 1150 Varnum Street NE Washington DC 20017 521275583 501(C)(3) 125000 Screening Providence Portland Medical Center 4805 NE Glisan St 5F40 Portland OR 97213 930386906 501(C)(3) 269970 Research Research Advocacy Network 6505 West Park Boulevard Plano TX 75093 352209499 501(C)(3) 58800 Research Roswell Park Alliance Foundation Elm Carlton Sts RSC 234 Buffalo NY 14263 161391608 501(C)(3) 150000 Research Rush University 1700 West Van Buren Chicago IL 60612 362174823 501(C)(3) 120000 Research Sanford Research 2301 East 60th Street North Sioux Falls SD 57104 460450378 501(C)(3) 30000 Research Scripps Research Institute 10550 North Torrey Pines Road TCP- La Jolla CA 92037 330435954 501(C)(3) 12000 Research Society for Surgical Oncology 85 W Algonquin Road Arlington Heights IL 60005 136161070 501(C)(3) 238500 Research Society for Womens Health Research 1025 Connecticut Avenue NW Washington DC 20036 521694732 501(C)(3) 247699 Research South East Alaska 3245 Hospital Drive Juneau AK 99801 920056274 501(C)(3) 21250 Screening Stanford University PO Box 44253 San Francisco CA 941444253 941156365 501(C)(3) 172192 Research SUNY at Buffalo 402 Crofts Hall Buffalo NY 14260 141368361 501(C)(3) 28722 Research SUNY at Stony Brook W5510 Melville Library Stony Brook NY 11794 141368361 501(C)(3) 29846 Research Texas Tech Univ Health Sciences Ctr 3601 4th Street Lubbock TX 794306274 752668014 501(C)(3) 18086 Research The Alliance of Pennsylvania Councils 3461 Market Street Camp Hill PA 17011 251888581 501(C)(3) 53408 Screening The ASCO Cancer Foundation 2318 Mill Road Alexandria VA 22314 136180380 501(C)(3) 450000 Research The Caring Foundation PO Box 2266 Cheyenne WY 82003 830292601 501(C)(3) 308383 Screening The General Hospital Corp 50 Staniford Street Suite 1001 Boston MA 02114 041564655 501(C)(3) 167865 Research The James Ewing Foundation 520 Green Bay Road Winnetka IL 60093 112498503 501(C)(3) 57500 Research The Salk Institute 10010 North Torrey Pines Road La Jolla CA 920371002 956136024 501(C)(3) 225000 Research The University of Chicago 5801 South Ellis Avenue Chicago IL 60637 362177139 501(C)(3) 60000 Research The Wistar Institute 3601 Spruce Street Philadelphia PA 191044265 236434390 501(C)(3) 137566 Research Thomas Jefferson University 1020 Walnut Street Philadelphia PA 191075587 232829095 501(C)(3) 1396196 Research Trustees of Columbia Univ 615 West 131st Street New York NY 10027 135598093 501(C)(3) 191616 Research Tufts University 136 Harrison Avenue Boston MA 02111 043532914 501(C)(3) 51523 Research Univ of Colorado Denver Health Sciences Ctr PO Box 910238 Denver CO 802910238 846000555 501(C)(3) 268084 Research Univ of Kentucky Research Foundation 102 Kinkead Hall Lexington KY 40506 746000949 501(C)(3) 199909 Research Univ of North Carolina at Chapel Hill 104 Airport Drive Suite 2200 CB Chapel Hill NC 275991350 566001393 501(C)(3) 910922 Research Univ of North Carolina at Charlotte 9201 University City Boulevard Charlotte NC 282230001 566001393 501(C)(3) 11691 Research Univ of TX MD Anderson Cancer Center 1515 Holcombe Blvd Houston TX 77030 746001118 501(C)(3) 939713 Research University Miami School of Medicine 1400 NW 10th Avenue Miami FL 33136 590624458 501(C)(3) 254467 Research University of Alabama at Birmingham 1720 2nd Avenue South Birmingham AL 35294 636005396 501(C)(3) 823386 Research University of California at San Diego 9500 Gilman Drive MC 0009 La Jolla CA 92093 956006144 501(C)(3) 204000 Research University of California at San Francisco 3333 California St Suite 315 San Francisco CA 94118 946036493 501(C)(3) 452610 Research University of California-Berkeley 2195 Hearst Avenue Room 130 Berkeley CA 947201103 946090626 501(C)(3) 48000 Research University of California-Davis Cashiers Office PO Box 989062 West Sacramento CA 957989062 946036494 501(C)(3) 40000 Research University of California-Irvine Biological Science 3 Suite 1400 Irvine CA 926971050 952226406 501(C)(3) 172000 Research University of California-Los Angeles 10920 Wilshire Boulevard Suite 107 Los Angeles CA 900959000 956006143 501(C)(3) 195432 Research University of California-San Francisco 1855 Folsom Street MCB 425 Box 08 San Francisco CA 941430897 946036493 501(C)(3) 939987 Research University of Delaware 30 Lovett Avenue Newark DE 19716 516000279 501(C)(3) 93384 Research University of Illinois at Chicago PO Box 20787 Springfield IL 627080787 376000511 501(C)(3) 60000 Research University of Kansas Medical Center 3901 Rainbow Boulevard MSN 1039 Kansas City KS 66160 481108830 501(C)(3) 398657 Research University of Louisville 521 Stevenson Hall Louisville KY 40292 611029626 501(C)(3) 80000 Research University of Maryland-Baltimore 1000 Hilltop Circle Baltimore MD 21250 311678679 501(C)(3) 331999 Research University of Michigan Health Systems 3003 S State St Rm 1054 3086 Wolv Ann Arbor MI 481091274 386006309 501(C)(3) 941872 Research University of Minnesota 200 Oak Street SE Campus Code 2003 Minneapolis MN 55455 416007513 501(C)(3) 149867 Research University of Nebraska 985100 Nebraska Medical Center Omaha NE 681985100 470049123 501(C)(3) 48000 Research University of NoCarolina at Chapel Hill 104 Airport Drive Suite 2200 CB Chapel Hill NC 275991350 566001393 501(C)(3) 100000 Education University of Oklahoma Health Sciences C 1100 N Lindsay SCB 228 Oklahoma City OK 73104 736017987 501(C)(3) 153707 Research University of Pennsylvania 3451 Walnut Street P-211 Franklin Philadelphia PA 191046205 231352685 501(C)(3) 950659 Research University of Pittsburgh 139 University Place Pittsburgh PA 15260 250966691 501(C)(3) 96225 Research University of Southern California 1540 Alcazar St CHP-100 Los Angeles CA 90033 951642394 501(C)(3) 548467 Research University of Texas at Health Science Ce 7000 Fannin Street Houston TX 77030 741587488 501(C)(3) 8985 Research University of Utah 201 South Presidents Circle Room Salt Lake City UT 841129020 876000525 501(C)(3) 132000 Research University of Vermont 85 South Prospect Street Burlington VT 05405 030179440 501(C)(3) 150000 Research University of Virginia PO Box 400195 Charlottesville VA 22904 541682176 501(C)(3) 130138 Research University of Washington 3917 University Way NE Seattle WA 98105 916001537 501(C)(3) 519137 Education and Research University of Wisconsin 21 North Park St Suite 6401 Madison WI 537151218 396006492 501(C)(3) 138525 Research UNT Health Science Center 3500 Camp Bowie Blvd Fort Worth TX 761072699 756064033 501(C)(3) 10861 Research UT Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio TX 78229 741586031 501(C)(3) 295412 Research UT Southwestern Medical Center at Dallas 5323 Harry Hines Blvd MC8585 Dallas TX 75390 756002868 501(C)(3) 132000 Research UTMD Anderson Cancer Ctr 1515 Holcombe Boulevard Unit 1644 Houston TX 770304009 746001118 501(C)(3) 6127868 Research Vaccine & Gene Therapy Institute of Fla 9801 SW Discovery Way Port St Lucie FL 34987 364631835 501(C)(3) 11857 Research Van Andel Research Institute 333 Bostwick Avenue NE Grand Rapids MI 49503 522000823 501(C)(3) 150000 Research Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Nashville TN 372038480 620476822 501(C)(3) 379554 Research Virginia Commonwealth University PO Box 843039 Richmond VA 232843038 546001758 501(C)(3) 29954 Research Washington University at St Louis 700 Rosedale Avenue Campus Box 103 Saint Louis MO 63112 430653611 501(C)(3) 615995 Research Wayne State University 5057 Woodward Avenue 13th Floor Detroit MI 48202 383555142 501(C)(3) 12000 Research West Virginia University 886 Chestnut Ridge Road Morgantown WV 265066845 550665758 501(C)(3) 149984 Research Whitehead Institute 9 Cambridge Center Cambridge MA 021421479 061043412 501(C)(3) 200000 Research Winchester Medical Center Foundation 220 Campus Boulevard Winchester VA 22601 542013319 501(C)(3) 34284 Screening Yale University 47 College Street Ste 216 New Haven CT 065103209 060646973 501(C)(3) 85124 Research Young Survival Coalition 61 Broadway Suite 2235 New York NY 10006 134057685 501(C)(3) 50000 Research 146 Procedures for Monitoring the Use of Grants Schedule I, Part I, Line 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING RESEARCH, EDUCATION, SCREENING, AND TREATMENT GRANTS FROM THE TIME OF INITIAL AWARD THROUGH COMPLETION SEEK TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING THE HIGHEST STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND FUNDING PROCESS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D.-LEVEL SCIENTIFIC GRANTS MANAGER. THE GRANTEE IS REQUIRED TO SUBMIT SCIENTIFIC PROGRESS REPORTS ON EACH ANNIVERSARY OF THE GRANT START DATE FOR THE DURATION OF THE PROJECT, EXCEPT FOR THE FINAL YEAR OF THE GRANT WHEN A FINAL REPORT IS DUE NO LATER THAN 30 DAYS AFTER THE END DATE OF THE GRANT TERM. A SCIENTIFIC PROGRESS REPORT ALSO IS DUE IF THE GRANTEE IS REQUESTING AN EXTENSION TO THE END OF THE GRANT TERM OR ACCELERATION OF THE GRANT TERM. THE GRANTEE MUST SUBMIT REQUESTS FOR ANY CHANGES TO THE DESIGN OF THE FUNDED RESEARCH PROJECT, OR CHANGES TO PERSONNEL AND THEIR LEVEL OF EFFORT FOR KOMEN'S APPROVAL PRIOR TO IMPLEMENTING SAID CHANGES. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET, AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. ANNUAL FINANCIAL REPORTS ARE DUE NO LATER THAN 30 DAYS AFTER EACH ANNIVERSARY OF THE GRANT START DATE FOR THE DURATION OF THE GRANT TERM, WITH THE EXCEPTION OF THE FINAL FINANCIAL REPORT, WHICH IS DUE NO LATER THAN 60 DAYS AFTER THE END DATE OF THE GRANT TERM. ALL EXPENDITURES MUST BE REPORTED IN UNITED STATES DOLLARS ($USD). THE GRANTEE MUST SUBMIT A REQUEST FOR A BUDGET CHANGE IN THE EVENT THE GRANTEE WISHES TO MOVE FUNDS ACROSS BUDGET CATEGORIES IN EXCESS OF THE ALLOWABLE LIMITS AS STATED WITHIN THE POLICIES AND PROCEDURES. UNEXPENDED FUNDS MUST BE REMITTED WITH THE FINAL FINANCIAL REPORT TO KOMEN, UNLESS OTHERWISE SPECIFIED. WITH REASONABLE PRIOR NOTICE TO THE GRANTEE, KOMEN MAY REQUIRE ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE AND ALSO MAY REQUIRE THE GRANTEE TO PARTICIPATE IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS OR OTHER SPEAKING ENGAGEMENTS. AS PART OF ITS OVERSIGHT OF RESEARCH PROGRESS, KOMEN MAY ADJUST THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM WITH PRIOR WRITTEN NOTICE TO THE GRANTEE. KOMEN WILL NOT BE RESPONSIBLE FOR A) ANY EXPENDITURE MADE PRIOR TO THE EFFECTIVE DATE OR AFTER THE TERMINATION OF THE GRANT, B) COMMITMENTS MADE DURING THE GRANT TERM BUT NOT PAID WITHIN SIXTY (60) DAYS FOLLOWING THE EXPIRATION OF THE GRANT AGREEMENT, C) EXPENDITURES THAT ARE NOT PERMITTED AS DESCRIBED WITHIN THE RFA, OR D) ANY EXPENDITURE THAT IS INCONSISTENT WITH THE APPROVED RESEARCH PLAN AND BUDGET OR THAT EXCEEDS THE TOTAL AMOUNT OF THE GRANT. KOMEN, OR ITS DESIGNATED REPRESENTATIVES, SHALL HAVE THE RIGHT TO REQUEST AND RECEIVE FROM A GRANTEE, OR ANY OF ITS SUBCONTRACTORS, COPIES OF ANY AND ALL DOCUMENTS AND OTHER INFORMATION RELATED TO THE GRANT AT ANY TIME DURING OR AFTER THE TERM OF THE GRANT. THIS RIGHT INCLUDES, BUT IS NOT LIMITED TO, THE RIGHT TO REVIEW ALL FINANCIAL BOOKS AND RECORDS RELATED TO THE GRANT AND TO PERFORM AN AUDIT OF ALL EXPENSES RELATED DIRECTLY OR INDIRECTLY TO THE GRANT. KOMEN'S POLICIES FOR MANAGING EDUCATION, SCREENING, AND TREATMENT GRANTS REQUIRE THAT ALL GRANTEES SIGN A GRANT AGREEMENT, WHICH SETS FORTH THE TERMS OF THE GRANT, INCLUDING THE PURPOSE OF THE GRANT, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AND AUDIT AND EARLY TERMINATION RIGHTS FOR KOMEN. PROGRESS IS MONITORED THROUGHOUT THE GRANT TERM BY A COMMUNITY HEALTH GRANTS MANAGER. THE GRANTEE IS REQUIRED TO SUBMIT PROGRESS REPORTS (TYPICALLY EVERY SIX MONTHS) THAT DETAIL PROGRESS TOWARD MEETING EACH OF THE OBJECTIVES AND ANY CHALLENGES ENCOUNTERED. THE REPORT MUST ALSO INCLUDE A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES). THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH THE GRANTEE, WHEN APPROPRIATE, TO BUILD A STRONGER RELATIONSHIP WITH THE GRANTEE; TO GAIN A BETTER UNDERSTANDING OF ITS WORK; AND TO ADDRESS ANY CHALLENGES OR PROBLEMS THE GRANTEE IS FACING. ANY CHANGES TO THE PROJECT MUST BE APPROVED BY KOMEN'S GRANTS MANAGER IN WRITING IN ADVANCE OF THE CHANGE. A FINAL REPORT MUST BE PROVIDED AT THE COMPLETION OR EARLY TERMINATION OF THE GRANT AND MUST INCLUDE, AMONG OTHER THINGS, A FINANCIAL REPORT AND AN EVALUATION OF THE PROGRAM'S ACCOMPLISHMENTS AND IMPACT IN THE COMMUNITY. ANY UNEXPENDED FUNDS MUST BE REMITTED WITH THE FINAL REPORT TO KOMEN UNLESS OTHERWISE DIRECTED. X true true X X X X X true false false false false false false false false Lynn Erdman VP Community Health (End 5/13) 109504 0 0 0 44802 0 5808 0 11351 0 171465 0 0 0 Kay Merrell VP, Human Resources 187755 0 20000 0 3590 0 10661 0 18657 0 240663 0 0 0 Mark Nadolny Chief Financial Officer 314891 0 0 0 4433 0 14025 0 19795 0 353144 0 0 0 Nancy G Brinker Founder & CHAIR GLOBAL STRTGY 469282 0 0 0 11502 0 15221 0 10481 0 506486 0 0 0 Dr Judith Salerno CEO (Begin 9/13) 140857 0 66000 0 2263 0 0 0 3399 0 212519 0 0 0 Miguel Perez VP Affiliate Ntwrk (BEG. 9/14) 144044 0 0 0 2727 0 0 0 8392 0 155163 0 0 0 Wendy Carter Director, Global Outreach 167150 0 0 0 1896 0 0 0 7569 0 176615 0 0 0 Andrea Rader Managing Director, Comm. 154853 0 0 0 3222 0 6358 0 15229 0 179662 0 0 0 Victoria Wolodzko Mng Director, Grants & PrOG AD 152233 0 0 0 2574 0 9147 0 7727 0 171681 0 0 0 Adine Zornow Director, Development 142342 0 0 0 1833 0 0 0 12785 0 156960 0 0 0 Ellen Willmott Gen Counsel & Secy 254229 0 0 0 2900 0 7634 0 9000 0 273763 0 0 0 Lesley Lurie Assistant Secretary 191723 0 0 0 2266 0 10546 0 16483 0 221018 0 0 0 David Dawson VP, Information Technology 213470 0 0 0 2119 0 9575 0 24266 0 249430 0 0 0 Chandini Portteus CHIEF MISSION OFFCR (BEG 6/13) 243034 0 0 0 2095 0 14926 0 11027 0 271082 0 0 0 Dorothy Jones VP, Marketing (End 12/13) 243015 0 0 0 48271 0 9960 0 15253 0 316499 0 0 0 Carol Corcoran SVP Global Networks (End 8/13) 157749 0 0 0 3549 0 9572 0 7079 0 177949 0 0 0 FORM 990, SCHEDULE J, PART I, LINE 1A SUPPLEMENTAL COMPENSATION INFORMATION FIRST CLASS AND BUSINESS CLASS FARES FOR DOMESTIC TRAVEL, CANADA, THE CARIBBEAN, CENTRAL AMERICA, AND MEXICO ARE NOT REIMBURSABLE. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND/OR COUPONS MAY BE USED FOR NO-COST UPGRADES. FIRST CLASS TRAVEL WAS APPROVED FOR ONE INDIVIDUAL ON AN OCCASIONAL BASIS DUE TO MEDICAL NECESSITY. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND UPGRADES ARE USED TO MINIMIZE COST. Schedule J, Part I, line 4a During calendar year 2013 the following severance payments were made: Dorothy Jones $46,096 Lynn Erdman $42,587 X 25800 cost or sales price X 2 2766 cost or sales price false true false VOLUNTEERS FORM 990, PART I, QUESTION 6 VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES. FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTS SUSAN G. KOMEN IS THE WORLD'S LARGEST BREAST CANCER ORGANIZATION, FUNDING MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT WHILE PROVIDING REAL-TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $840 MILLION IN RESEARCH AND PROVIDED $1.8 BILLION IN FUNDING TO SCREENING, EDUCATION, TREATMENT AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 30 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. A - RESEARCH KOMEN HAS CONTRIBUTED TO MAJOR ADVANCES IN BREAST CANCER RESEARCH SINCE ITS FOUNDING IN 1982. KOMEN'S RESEARCH PROGRAMS ARE DESIGNED TO ADVANCE THE TRANSLATION OF RESEARCH DISCOVERIES INTO NEW WAYS TO DETECT, DIAGNOSE, TREAT, AND PREVENT BREAST CANCER, IN ORDER TO REDUCE BREAST CANCER INCIDENCE AND MORTALITY WITHIN THE NEXT DECADE. TO ENSURE MAXIMUM IMPACT FOR ITS RESEARCH DOLLARS, KOMEN IS GUIDED BY A SCIENTIFIC ADVISORY BOARD, A GROUP OF INTERNATIONALLY RECOGNIZED DOCTORS, SCIENTISTS AND ADVOCATES, AND CONSULTS WITH THE KOMEN SCHOLARS, A GROUP COMPRISED OF 60 DOCTORS, SCIENTISTS AND ADVOCATES. KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS, AND ORGANIZATIONS AROUND THE WORLD THROUGH A TRANSPARENT AND RIGOROUS REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH DOLLARS. IN FISCAL YEAR 2014, KOMEN AWARDED 116 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS, AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING AUSTRALIA, BELGIUM, CANADA, ENGLAND, ISRAEL, ITALY, SPAIN, AND SWITZERLAND. THE FOLLOWING REQUEST-FOR-APPLICATIONS (RFA) GRANT OPPORTUNITIES WERE OFFERED BY KOMEN DURING FISCAL YEAR 2014: POSTDOCTORAL FELLOWSHIPS (PDF): GRANTS SEEK TO ATTRACT AND SUPPORT PROMISING SCIENTISTS EMBARKING ON CAREERS DEDICATED TO BREAST CANCER RESEARCH WHO HAVE NO MORE THAN 3 YEARS POST-COMPLETION OF THEIR MOST RECENT CLINICAL FELLOWSHIP, 5 YEARS POST-COMPLETION OF THEIR MOST RECENT RESIDENCY (FOR PHYSICIANS), OR 5 YEARS POST-COMPLETION OF THEIR MOST RECENT PHD. BY PROVIDING FUNDING TO OUTSTANDING POSTDOCTORAL/POSTGRADUATE FELLOWS UNDER THE GUIDANCE OF A MENTOR, KOMEN SEEKS TO ENSURE THAT A DIVERSE POOL OF HIGHLY TRAINED SCIENTISTS WILL EMERGE AS THE NEXT GENERATION OF LEADERS IN THE FIELD OF BREAST CANCER RESEARCH. PDF GRANTS PROVIDE SUPPORT FOR RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY, AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. GRADUATE TRAINING IN DISPARITIES RESEARCH (GTDR): GTDR GRANTS (FORMERLY POST-BACCALAUREATE TRAINING IN DISPARITIES RESEARCH GRANTS) ARE INTENDED TO ESTABLISH AND/OR TO SUSTAIN A TRAINING PROGRAM FOR A MINIMUM OF THREE GRADUATE STUDENTS WHO ARE SEEKING CAREERS DEDICATED TO UNDERSTANDING AND ELIMINATING DISPARITIES IN BREAST CANCER OUTCOMES ACROSS POPULATION GROUPS. CAREER CATALYST RESEARCH (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN SIX YEARS AT THE TIME OF FULL APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. CCR GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY, AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. KOMEN'S RESEARCH INVESTMENT THROUGH THE ABOVE GRANT MECHANISMS WILL SUPPORT PROJECTS INCLUDING, BUT NOT LIMITED TO, THE FOLLOWING GOALS: -DEVELOPING TARGETED THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER -UNDERSTANDING BREAST CANCER PROGRESSION AND METASTASIS -VACCINE DEVELOPMENT FOR BREAST CANCER TREATMENT -PREDICTING RISK USING IMAGING -IMPROVING TOXICITY PREDICTION FOR OLDER WOMEN -IMPROVING TREATMENT RESPONSE -DEVELOPING NEW IMAGING TECHNIQUES TO IMPROVE DIAGNOSIS -OVERCOMING BREAST CANCER DISPARITIES IN LOW-INCOME WOMEN OPPORTUNITY GRANTS / SPONSORED PROGRAMS AND PARTNERSHIP GRANTS: THESE GRANTS SUPPORT SPECIAL RESEARCH PROJECTS, PROGRAMS, AND COLLABORATIONS THAT LEVERAGE RESEARCH AND COMMUNITY RESOURCES TO FACILITATE THE DEVELOPMENT OF THE INFRASTRUCTURE, TOOLS, AND OTHER MEANS TO ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES FROM BENCH TO BEDSIDE TO CURBSIDE. EXAMPLES OF OPPORTUNITY GRANTS/SPONSORED PROGRAMS & PARTNERSHIP GRANTS COMMITTED IN FISCAL YEAR 2014 INCLUDE: -SUPPORT FOR THE ACCELERATING ANTI-CANCER DRUG DEVELOPMENT WORKSHOP, WHICH IS DESIGNED FOR SCIENTISTS AND CONSUMER ADVOCATES WITH CLINICAL TRIAL EXPERIENCE WHO HAVE AN INTEREST IN NEW APPROACHES TO DEVELOPING OR ENHANCING AGENTS OR COMBINATIONS OF AGENTS FOR THE DIAGNOSIS, TREATMENT OR PREVENTION OF CANCER. THIS GROUNDBREAKING WORKSHOP IS DESIGNED TO BRING TOGETHER LEADERS IN CLINICAL AND TRANSLATIONAL CANCER RESEARCH FROM ACADEMIA, INDUSTRY, NCI AND FDA TO ASSIST INVESTIGATORS IN UNDERSTANDING AND IMPROVING THE PROCESS OF CANCER DRUG DEVELOPMENT. THE GOAL IS TO EXPEDITE THE DEVELOPMENT AND VALIDATION PROCESSES FOR NEW ANTICANCER AND CANCER PREVENTION AGENTS, SO THEY CAN BE MADE AVAILABLE TO PATIENTS AT AN ACCELERATED RATE. -SUPPORT TO THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) FOR AACR SCIENTIFIC CONFERENCES THAT: -HIGHLIGHT THE BEST AND LATEST FINDINGS IN MAJOR AREAS OF CANCER RESEARCH, INCLUDING PREVENTION AND HEALTH DISPARITIES; -PROVIDE INVESTIGATORS WITH NETWORKING OPPORTUNITIES THAT HELP ADVANCE SCIENTIFIC PROGRESS; -PROMOTE TRAINING PROGRAMS THAT PROVIDE ADVOCATES WITH A SOLID BACKGROUND IN CANCER RESEARCH AND STIMULATE COLLABORATIVE INTERDISCIPLINARY INTERACTIONS AND PARTNERSHIPS AMONG THE LEADERS OF THE SCIENTIFIC AND CANCER SURVIVOR AND PATIENT ADVOCACY COMMUNITIES WORLDWIDE; AND -PROVIDE SCIENTIFIC AWARDS WHICH RECOGNIZE INVESTIGATORS FOR SIGNIFICANT CONTRIBUTIONS TO THE FIELD. B - EDUCATION KOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THE FIGHT AGAINST BREAST CANCER. OUR WEBSITE, WWW.KOMEN.ORG, PROVIDES SAFE, ACCURATE, COMPREHENSIVE, AND UNBIASED INFORMATION ABOUT BREAST CANCER BASED UPON SCIENTIFIC EVIDENCE, AS WELL AS INFORMATION ABOUT OUR RESEARCH PROGRAMS, COMMUNITY PROGRAMS, VOLUNTEER OPPORTUNITIES AND EVENTS. THE "UNDERSTANDING BREAST CANCER" SECTION OF THE WEBSITE, CO-DEVELOPED WITH HARVARD MEDICAL SCHOOL FACULTY AND DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER STAFF, RECEIVED MORE THAN FIVE MILLION PAGE VIEWS DURING FISCAL YEAR 2014. KOMEN ALSO PRODUCES EVIDENCE-BASED, EASY-TO-READ EDUCATIONAL MATERIALS. KOMEN AND ITS AFFILIATES DISTRIBUTED MORE THAN THREE MILLION EDUCATIONAL MATERIALS IN FISCAL YEAR 2014. EXAMPLES OF KOMEN EDUCATIONAL MATERIALS INCLUDE THE FOLLOWING: -BREAST SELF-AWARENESS MESSAGES CARDS IN 27 LANGUAGES AND FOR 28 SPECIFIC AUDIENCES -BREAST CANCER AWARENESS AND BREAST CANCER SPECIFIC BROCHURES AND FACT SHEETS -BOOKLETS WITH SUPPORT INFORMATION FOR SURVIVORS AND CO-SURVIVORS THE SUSAN G. KOMEN "1-877 GO KOMEN" BREAST CARE HELPLINE OFFERS BREAST CANCER EDUCATION, PSYCHOSOCIAL SUPPORT AND INFORMATION ABOUT RESOURCES AVAILABLE FOR PATIENTS, FAMILIES AND FRIENDS. THE HELPLINE OPERATES FROM 9 A.M. - 10 P.M. ET. DURING FISCAL YEAR 2014, THE KOMEN BREAST CANCER HELPLINE RESPONDED TO MORE THAN 14,000 CALLS AND MORE THAN 700 EMAILS. WHILE OLDER AFRICAN AMERICAN WOMEN ARE LESS LIKELY TO BE DIAGNOSED WITH BREAST CANCER THAN CAUCASIAN WOMEN, AFRICAN AMERICAN WOMEN ARE MORE LIKELY TO DIE FROM THE DISEASE AT EVERY AGE. KOMEN'S CIRCLE OF PROMISE PROGRAM ENGAGES AFRICAN AMERICAN WOMEN, AND BLACK WOMEN AROUND THE WORLD, IN THE FIGHT AGAINST BREAST CANCER. ACTIVITIES ARE AIMED TO: -MOBILIZE THE COMMUNITY TO ENSURE THAT WOMEN EVERYWHERE HAVE ACCESS TO THE CARE THEY NEED; -EMPOWER WOMEN TO MAKE A PROMISE TO RECLAIM THEIR LIVES, THEIR HEALTH AND TO BE STRONG ADVOCATES IN THEIR COMMUNITIES; AND -DISPEL MYTHS IN THESE COMMUNITIES THAT PREVENT WOMEN FROM GETTING TREATMENT FOR BREAST CANCER. IN ADDITION, KOMEN PARTNERS WITH NON-PROFIT ADVOCACY ORGANIZATIONS TO PROVIDE OVER 475 TRAVEL SCHOLARSHIPS TO SEVERAL EDUCATIONAL CONFERENCES DEDICATED TO THE CRITICAL ISSUES FACING BREAST CANCER PATIENTS AND THEIR FAMILIES. IN FY14, THESE CONFERENCES INCLUDED: -THE CONFERENCE FOR YOUNG WOMEN AFFECTED BY BREAST CANCER HOSTED BY LIVING BEYOND BREAST CANCER (LBBC) -THE YOUNG SURVIVAL COALITION, LBBC'S ANNUAL CONFERENCE FOR WOMEN LIVING WITH METASTATIC BREAST CANCER -FACING OUR RISK EMPOWERED (FORCE) 2014 ANNUAL CONFERENCE FOR PEOPLE AND FAMILIES AFFECTED BY HEREDITARY CANCER OR A BRCA MUTATION CANCER KILLS MORE PEOPLE, WORLDWIDE, THAN TB, HIV/AIDS AND MALARIA COMBINED AND CANCER IS GROWING EXPONENTIALLY IN LOW-T Describe the Process used by Management &/or Governing Body to Review 990 Form 990, Part VI, Question 11b MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVELS OF MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS REVIEWS AND MAKES AN APPROVAL RECOMMENDATION REGARDING THE FORM 990 TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS APPROVES THE FORM 990 PRIOR TO THE FORM BEING FILED. Description of Process to Monitor Transactions for Conflicts of Interest Form 990, Part VI, Question 12c KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS, AND ADVISORY BOARDS TO DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST THEY MAY HAVE. ANY CONFLICTS ARE THEN REVIEWED BY MANAGEMENT AND THE AUDIT COMMITTEE AND APPROPRIATE MEASURES ARE TAKEN. ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS AND ADVISORY BOARDS ARE REQUIRED TO UPDATE THEIR CONFLICT OF INTEREST DISCLOSURES DURING THE YEAR. Offices & Positions for Which Process was Used, & Year Process was Begun Form 990, Part VI, Questions 15a and 15b THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE PRESIDENT/CHIEF EXECUTIVE OFFICER, THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER EMPLOYEES, GRANTING THE CEO AUTHORITY TO DETERMINE ACTUAL COMPENSATION LEVELS WITHIN AN APPROVED RANGE, AND INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. FOR THE POSITIONS OF PRESIDENT/CEO AND FOUNDER/CHAIR OF GLOBAL STRATEGY, EXTERNAL BENCHMARKING WAS CONDUCTED TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION. Avail of Gov Docs, Conflict of Interest Policy, & Fin Stmts to Gen Public Form 990, Part VI, Question 19 Komen's financial statements, conflict of interest policy and the Form 990 are publicly available on our website. The Certificate of Formation is available from the Texas Secretary of State, and other governing documents are made available as required by state law. Form 1023 is not online but is available to the public upon request. Additional detail on event production expenses included on other exp line Form 990, Part IX, LINE 24 Komen purchases all T-Shirts for the 138 Susan G. Komen Race for the Cure events conducted by the Komen Affiliates during the year. OTHER CHANGES IN NET ASSETS OR FUND BALANCES FORM 990, PART XI, LINE 9 RESCINDED GRANTS - $3,116,992